Canada Markets closed

Mind Medicine (MindMed) Inc. (MMDCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.06500.0000 (0.00%)
At close: 09:46AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0650
Open0.0650
BidN/A x N/A
AskN/A x N/A
Day's Range0.0650 - 0.0650
52 Week Range0.0650 - 0.0650
Volume551
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    MindMed Announces At-The-Market Offering

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the "Company"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced today that the registration statement on Form S-3, filed on May 4, 2022, was declared effective by the U.S. Securities and Exchange Commission, which includes a prospectus for an at-the-market equity offering under which the Company may offer and sell its Subordinate Voting Shares or common shares re-designated f

  • CNW Group

    MindMed Reports First Quarter 2022 Financial Results and Business Highlights

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today reported its financial results for the quarter ended March 31, 2022.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Glass House to acquires new California cannabis dispensaries for $22.6 million. Trulieve first quarter revenue increased 4% to $318.3 million; the company expects to sell over $1 billion of cannabis in 2022. Key Takeaways; Psychedelic Sector Awakn’s Prof. David Nutt and Prof. Celia Morgan gave exceptional presentations at Psych Symposium: London […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive.